company background image
CARE logo

Dialogue Health Technologies TSX:CARE Stock Report

Last Price

CA$5.14

Market Cap

CA$346.0m

7D

0.2%

1Y

106.4%

Updated

04 Oct, 2023

Data

Company Financials +

Dialogue Health Technologies Inc.

TSX:CARE Stock Report

Market Cap: CA$346.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

CARE Stock Overview

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. More details

CARE fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Dialogue Health Technologies Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Dialogue Health Technologies
Historical stock prices
Current Share PriceCA$5.14
52 Week HighCA$5.16
52 Week LowCA$2.05
Beta2.78
1 Month Change0.69%
3 Month Change66.88%
1 Year Change106.43%
3 Year Changen/a
5 Year Changen/a
Change since IPO-63.96%

Recent News & Updates

Recent updates

Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 90% Above Its Share Price

Mar 14
Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 90% Above Its Share Price

Dialogue Health Technologies Inc. (TSE:CARE) Just Reported Earnings, And Analysts Cut Their Target Price

Nov 17
Dialogue Health Technologies Inc. (TSE:CARE) Just Reported Earnings, And Analysts Cut Their Target Price

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

Jun 28
An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 48% Undervalued

Feb 11
An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 48% Undervalued

Calculating The Fair Value Of Dialogue Health Technologies Inc. (TSE:CARE)

Nov 07
Calculating The Fair Value Of Dialogue Health Technologies Inc. (TSE:CARE)

Shareholder Returns

CARECA HealthcareCA Market
7D0.2%0.5%-0.7%
1Y106.4%30.2%16.8%

Return vs Industry: CARE exceeded the Canadian Healthcare industry which returned 1.5% over the past year.

Return vs Market: CARE exceeded the Canadian Market which returned -0.8% over the past year.

Price Volatility

Is CARE's price volatile compared to industry and market?
CARE volatility
CARE Average Weekly Movement12.0%
Healthcare Industry Average Movement4.2%
Market Average Movement8.3%
10% most volatile stocks in CA Market18.2%
10% least volatile stocks in CA Market2.9%

Stable Share Price: CARE's share price has been volatile over the past 3 months.

Volatility Over Time: CARE's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016240Cherif Habibdialogue.co

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company’s platform also enables its members and their dependents to access employee assistance program.

Dialogue Health Technologies Inc. Fundamentals Summary

How do Dialogue Health Technologies's earnings and revenue compare to its market cap?
CARE fundamental statistics
Market capCA$345.99m
Earnings (TTM)-CA$19.50m
Revenue (TTM)CA$95.88m

3.6x

P/S Ratio

-17.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CARE income statement (TTM)
RevenueCA$95.88m
Cost of RevenueCA$41.84m
Gross ProfitCA$54.03m
Other ExpensesCA$73.54m
Earnings-CA$19.50m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.29
Gross Margin56.36%
Net Profit Margin-20.34%
Debt/Equity Ratio1.0%

How did CARE perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/04 11:13
End of Day Share Price 2023/10/04 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dialogue Health Technologies Inc. is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Douglas TaylorCanaccord Genuity
Scott FletcherCIBC Capital Markets
David NewmanDesjardins Securities Inc.